RxDoctor Payments Data

Thomas Loftus, MD

Neurological Surgery · Austin, TXNPI 1548253503

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $374,853 of the $378,590 with a category attached, or 99.0%. 27 manufacturers reported payments, led by Biofusion Management And Manufacturing, LLC at 53.2% of the total. Reporting peaked in 2019 at $285,305 and has fallen 99.9% since, to $184 in 2025. Among neurological surgery clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$378,590in general payments, 2019–2025

Across 91 payments — averaging $4160.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biofusion Management And Manufacturing, LLC$201K
  • Osseus Fusion Systems, LLC$174K
  • Abbott$2K
  • Medtronic$285
  • Providence Medical Technology, Inc.$192
  • Johnson & Johnson$173
  • plus $927 from 21 others

What the payments were for

  • Royalty or licence$374,85399%
  • Food & beverage$3,7371%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$378,590 in reported general payments places this provider in the 95th percentile of 582 neurological surgery providers in Texas.

See all neurological surgery providers in Texas

Medicare billing

Part B allowed, 2024
$356,884
Medicare patients
322
Services billed
1,023

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen240$3,735
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen149$1,933
Gabapentin68$764
Tizanidine Hcl88$661
Tramadol Hcl59$661
Cyclobenzaprine Hcl46$436
Methocarbamol51$410
Pregabalin21$159

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Austin

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →